Molecular MedicinePublished 18 September 2024DeltaRex-G, tumor targeted retrovector encoding a CCNG1 inhibitor, for CAR-T cell therapy induced cytokine release syndromeGrace Haroun · Erlinda M. GordonFrontiers in Molecular Medicinedoi 10.3389/fmmed.2024.1461151
Molecular MedicinePublished 27 February 2024Editorial: Celebrating the 200th mendel’s anniversary: gene-targeted diagnostics and therapies for cancerNoah Federman · Erlinda M. Gordon · Sant P. Chawla · Frederick L. HallFrontiers in Molecular Medicinedoi 10.3389/fmmed.2024.1366963
